Tzield Under Expedited Review for Type 1 Diabetes Treatment Tzield, a monoclonal antibody, has been approved for stage 2 Type 1 diabetes and is now seeking approval for stage 3 disease.
India vs Pakistan: Rain-Affected Hong Kong Sixes 2025 Thriller Robin Uthappa and Bharat Chipli's powerful batting brought India a narrow …
Blood-spattered Fox Hunting Season Begins A blog by Chris Luffingham, deputy chief executive at the League Against Cruel Sports. Th…
Challenging the Zero-Sum Game Assumption The notion that equity markets are a 'zero-sum game', where active managers cannot outperform pas…